While no association was observed between use of biologics and incident PsA overall, specific biologic classes were ...

Otezla (apremilast) is an oral tablet commonly used to treat psoriatic arthritis in adults. Psoriatic arthritis is a long-lasting condition that affects the joints in people with psoriasis. Common ...

Weight loss after a psoriasis diagnosis lowers the risk of developing psoriatic arthritis and keeping weight off matters, but ...

P soriatic arthritis is an autoimmune condition where the body’s immune system mistakenly attacks joints and connective tissue. This leads to a cascade of inflammation that causes painful symptoms, ...

You probably already know about psoriasis—it’s when an overactive immune system leads to scaly, inflamed patches of skin. It’s so common (an estimated 8 million people in the U.S. have it) that ...

Depression and anxiety can worsen psoriatic arthritis symptoms and may be overlooked, highlighting the need for comprehensive ...

Managing either psoriatic arthritis (PsA) or psoriasis alone can be difficult, and when the two occur together — which is common — it’s even more challenging. The good news is that the right ...

Lifestyle risk factors, particularly obesity and smoking, contribute to elevated disease activity in psoriatic arthritis.

Learn how stress affects psoriatic arthritis and discover evidence-based techniques and daily habits to reduce flares, ...

What I Wish I Knew About Developing Psoriatic Arthritis So Young Why Psoriatic Arthritis (PsA) Causes Fatigue and How To Manage It What I Wish I Knew About Treating Chronic Pain in People With ...

AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for the treatment of children six years of age and older with ...